SYMBIOMIX
Dead / Abandoned — Abandoned — no statement of use filed (as of 06 May 2024)
What this means for you
This application is over — abandoned 06 May 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88282091
- Mark type
- Stylized text
- Filed
- 30 Jan 2019
- Published for opposition
- 08 Aug 2023
- Abandoned
- 06 May 2024
- Attorney of record
- Robert L. Powley
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and biological preparations used for the treatment of women's health infections, disorders, and diseases, specifically for the treatment of bacterial vaginosis, gynecologic infections, sexually transmitted diseases, breast cancer, ovarian and cervical cancer, and bone density disorders
Owner
- Symbiomix Therapeutics, LLC, Newark, NJ, US
- LUPIN INC., NAPLES, FL, US
- LUPIN INC., NAPLES, FL, US
Prosecution history
- 06 May 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 06 May 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Oct 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Aug 2023 — PUBLISHED FOR OPPOSITION
- 19 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jun 2023 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 13 Dec 2022 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 09 May 2022 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 01 Apr 2022 — ASSIGNED TO EXAMINER
- 13 Aug 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 17 Mar 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Nov 2020 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 11 May 2020 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED